Skip to main content

Inpatient diabetes


05-15-2020 | Inpatient diabetes | News

End of hospital stay glucose variability indicates readmission likelihood

People with diabetes who have high glucose variability on the last day of a hospital stay are at increased risk for being readmitted within 30 days, shows a US nationwide study.

05-07-2020 | COVID-19 | News

Study backs in-hospital hyperglycemia as COVID-19 mortality risk factor

A second study, this time from China, has pinpointed poor blood glucose control in hospital as a potential risk factor for mortality among patients with COVID-19.

04-27-2020 | COVID-19 | News

Uncontrolled hyperglycemia might be COVID-19 mortality risk factor

A descriptive analysis of US patients with COVID-19 reports a high in-hospital mortality rate in those with uncontrolled hyperglycemia.

04-24-2020 | COVID-19 | News

COVID-19 may trigger ketosis

Chinese researchers say that some COVID-19 patients present with ketosis, which may progress to diabetic ketoacidosis in those with diabetes.

04-17-2020 | Insulin glargine | News

Similar glycemic control with glargine U300, U100 for inpatients with type 2 diabetes

Hospitalized people with poorly controlled type 2 diabetes who are treated with insulin glargine U300 have comparable glycemic control to those given the U100 formulation, and may have a lower risk for hypoglycemia, researchers report.

04-09-2020 | Metformin | Highlight | News

Preoperative metformin use associated with better outcomes after major surgery

People with type 2 diabetes who are treated with metformin prior to undergoing major surgical interventions may have better postoperative outcomes than those without exposure to the drug, researchers report.

02-27-2020 | Ketoacidosis | News

Hyperosmolarity warns of poor outcomes in DKA patients

A large study backs hyperosmolarity as a key risk stratification factor for patients admitted to hospital with diabetic ketoacidosis.

11-13-2019 | Ketoacidosis | News

Hyperglycemic crisis combination linked with hospital deaths

A study of more than a thousand patients suggests that having both diabetic ketoacidosis and a hyperosmolar hyperglycemic state on arrival at hospital leads to more than twice the likelihood of death there than either condition alone.

10-03-2019 | Ketoacidosis | Highlight | News

Protocol with point-of-care testing improves speed, accuracy of DKA diagnosis

Implementing a nursing protocol that includes point-of-care testing at triage reduces the time to diabetic ketoacidosis diagnosis and the number of unnecessary intravenous placements in the pediatric emergency department, say researchers.

07-09-2019 | Inpatient diabetes | Highlight | News

Holistic approach can shorten diabetes inpatient stays

A nurse-delivered care program based on a whole-systems approach can lead to shorter hospital stays for patients with diabetes, UK researchers report.

04-01-2019 | Artificial pancreas systems | News

Closed-loop insulin feasible for inpatients needing nutritional support

Researchers show that closed-loop insulin delivery achieves markedly better glucose control than standard insulin management in hospitalized patients with hyperglycemia receiving enteral or parenteral nutrition.

11-28-2018 | Linagliptin | News

Linagliptin preferable to insulin in majority of surgical type 2 diabetes patients

Daily linagliptin is effective and reduces hypoglycemia risk relative to multidose insulin in type 2 diabetes patients with mild-to-moderate hyperglycemia who are undergoing non-cardiac surgery, suggest the results of a randomized controlled study.

06-26-2018 | Artificial pancreas systems | Highlight | News

Closed-loop delivery improves inpatient glucose control in type 2 diabetes

Fully closed-loop insulin delivery results in a markedly improved time in range among inpatients with type 2 diabetes receiving noncritical care, researchers have reported.

03-27-2017 | Inpatient diabetes | News

Remote monitoring may improve diabetes inpatient care

A study suggests that use of a virtual glucose management service can reduce hyper- and hypoglycemia among inpatients with diabetes by around a third.

12-09-2016 | Inpatient diabetes | News

DPP-4 inhibition may have role in inpatient diabetes care

Adding the dipeptidyl peptidase-4 inhibitor sitagliptin to basal insulin reduces bolus insulin requirements in hospitalized patients with type 2 diabetes, shows a randomised trial.

11-10-2016 | Artificial pancreas systems | News

Artificial pancreas could meet type 2 diabetes inpatient needs

A pilot randomized trial suggests that closed-loop insulin delivery is feasible for inpatients with insulin-dependent type 2 diabetes on the general ward.

Image Credits